What is the address of DOLLIMMO BELGIUM?

The registered office of DOLLIMMO BELGIUM is located at Rue Graham Bell 8, 1402 Nivelles.

Is DOLLIMMO BELGIUM still active?

Yes. According to the CBE (29 October 2026) DOLLIMMO BELGIUM is active, legal situation “Normale toestand”, started on 17 March 2021.

Is DOLLIMMO BELGIUM registered on Peppol?

Yes, DOLLIMMO BELGIUM is registered on the Peppol network with ID 0208:0765300009.

What is the enterprise number of DOLLIMMO BELGIUM?

The enterprise number of DOLLIMMO BELGIUM is BE0765300009.

When was DOLLIMMO BELGIUM founded?

DOLLIMMO BELGIUM was founded on 17 March 2021.

Who are the directors of DOLLIMMO BELGIUM?

According to the 2025 annual accounts, the directors of DOLLIMMO BELGIUM are: ADFINITIS SRL, NEXTGEN INVEST SRL, Martial DOLLINGER, Claire BECKER.

Is DOLLIMMO BELGIUM a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 March 2021; 5 annual accounts filed, latest fiscal year 2025; 4 directors known from the annual account.

How much profit did DOLLIMMO BELGIUM make in 2025?

DOLLIMMO BELGIUM recorded a loss after taxes of € 179,928 in financial year 2025.

What is the revenue of DOLLIMMO BELGIUM?

As a small company, DOLLIMMO BELGIUM is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -28,846.

Does DOLLIMMO BELGIUM have a website?

Yes, DOLLIMMO BELGIUM has a website at pharmatec.be.

DOLLIMMO BELGIUM (Private Limited) - Nivelles

Dossier DOLLIMMO BELGIUM, printed on 29 October 2026 from databakkes.be/en/0765300009/dollimmo-belgium. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 12 % of short-term debt in 2025; threshold 65 %.
Board fully replaced NBB

No director from three years ago is still active according to annual account 2025.

Financials

Financial year 2025

DOLLIMMO BELGIUM from Nivelles, company number BE0765300009, closed financial year 2025 with a result of € -179,928 after tax. For that financial year DOLLIMMO BELGIUM recorded a gross margin of € -28,846 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € -81,025 to € -179,928. The company made a loss. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 1.2 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -179,928

▼ 122 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 493,840

▼ 10% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -407,549.

Debts at end 2025

Bank debt

€ 4.9 million

▲ € 3.7 million vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 776,915

▲ 201% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -15,128 Gross margin 2022: € -15,128 First fiscal year in the series	-	€ -19,070 Gross margin 2024: € -19,070 First fiscal year in the series	€ -28,846 Gross margin 2025: € -28,846 ▼ € 9,776 vs 2024 (€ -19,070) Unfavourable step	▼ € 9,776
Profit after taxes	€ -43,920 Profit after taxes 2022: € -43,920 First fiscal year in the series	€ -68,489 Profit after taxes 2023: € -68,489 ▼ € 24,569 vs 2022 (€ -43,920) Unfavourable step	€ -81,025 Profit after taxes 2024: € -81,025 ▼ € 12,536 vs 2023 (€ -68,489) Unfavourable step	€ -179,928 Profit after taxes 2025: € -179,928 ▼ € 98,902 vs 2024 (€ -81,025) Unfavourable step	▼ € 98,902
Equity	€ 721,893 Equity 2022: € 721,893 First fiscal year in the series	€ 653,404 Equity 2023: € 653,404 ▼ 9% vs 2022 (€ 721,893) Unfavourable step	€ 1,072,379 Equity 2024: € 1,072,379 ▲ 64% vs 2023 (€ 653,404) Favourable step	€ 1,192,451 Equity 2025: € 1,192,451 ▲ 11% vs 2024 (€ 1,072,379) Favourable step	▲ 11%
Total debts	€ 868,076 Total debts 2022: € 868,076 First fiscal year in the series	€ 899,326 Total debts 2023: € 899,326 ▲ 4% vs 2022 (€ 868,076) Unfavourable step	€ 1,995,504 Total debts 2024: € 1,995,504 ▲ 122% vs 2023 (€ 899,326) Unfavourable step	€ 5,744,808 Total debts 2025: € 5,744,808 ▲ 188% vs 2024 (€ 1,995,504) Unfavourable step	▲ 188%
Cash	€ 1,145,439 Cash 2022: € 1,145,439 First fiscal year in the series	€ 100,255 Cash 2023: € 100,255 ▼ 91% vs 2022 (€ 1,145,439) Unfavourable step	€ 549,984 Cash 2024: € 549,984 ▲ € 449,729 vs 2023 (€ 100,255) Favourable step	€ 493,840 Cash 2025: € 493,840 ▼ 10% vs 2024 (€ 549,984) Unfavourable step	▼ 10%
Land & buildings	€ 444,276 Land & buildings 2022: € 444,276 First fiscal year in the series	€ 552,364 Land & buildings 2023: € 552,364 ▲ 24% vs 2022 (€ 444,276) Unchanged	€ 2,504,149 Land & buildings 2024: € 2,504,149 ▲ € 2 million vs 2023 (€ 552,364) Unchanged	€ 6,310,439 Land & buildings 2025: € 6,310,439 ▲ 152% vs 2024 (€ 2,504,149) Unchanged	▲ 152%
Retained profit	€ -78,107 Retained profit 2022: € -78,107 First fiscal year in the series	€ -146,596 Retained profit 2023: € -146,596 ▼ € 68,489 vs 2022 (€ -78,107) Unfavourable step	€ -227,621 Retained profit 2024: € -227,621 ▼ € 81,025 vs 2023 (€ -146,596) Unfavourable step	€ -407,549 Retained profit 2025: € -407,549 ▼ € 179,928 vs 2024 (€ -227,621) Unfavourable step	▼ € 179,928
Bank debt	€ 838,302 Bank debt 2022: € 838,302 First fiscal year in the series	€ 838,302 Bank debt 2023: € 838,302 Unchanged (€ 838,302) Unchanged	€ 1,200,000 Bank debt 2024: € 1,200,000 ▲ 43% vs 2023 (€ 838,302) Unfavourable step	€ 4,852,945 Bank debt 2025: € 4,852,945 ▲ € 3.7 million vs 2024 (€ 1,200,000) Unfavourable step	▲ € 3.7 million
Balance sheet total	€ 1,589,969 Balance sheet total 2022: € 1,589,969 First fiscal year in the series	€ 1,552,730 Balance sheet total 2023: € 1,552,730 ▼ 2% vs 2022 (€ 1,589,969) Unchanged	€ 3,067,883 Balance sheet total 2024: € 3,067,883 ▲ 98% vs 2023 (€ 1,552,730) Unchanged	€ 6,937,259 Balance sheet total 2025: € 6,937,259 ▲ 126% vs 2024 (€ 3,067,883) Unchanged	▲ 126%

Key figures of DOLLIMMO BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOLLIMMO BELGIUM?

What happened at DOLLIMMO BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: loss of € 179,928. Source: NBB ↗
2024 ADFINITIS SRL became a director. NBB
2024 Martial DOLLINGER stepped down as director. NBB
2024 NEXTGEN INVEST SRL became a director. NBB
2024 Claire BECKER stepped down as director. NBB
Mar 17, 2021 New establishment in Ukkel. KBO
Mar 17, 2021 Start of the company according to the CBE. KBO
2021 Claire BECKER became a director. NBB

In short

From € 43,920 loss in 2022 to € 179,928 loss in 2025.

Original PDFs at the National Bank ↗

Management

ADFINITIS SRL NEXTGEN INVEST SRL

DOLFINANCE

PHARMA FLEX

DOLLIMMO BELGIUM

Behind DOLLIMMO BELGIUM are ADFINITIS SRL and NEXTGEN INVEST SRL. The same people are also behind PHARMA FLEX. ADFINITIS SRL is also behind DOLFINANCE.

Directors

According to the 2025 annual accounts

ADFINITIS SRL

Director · represented by Martial Dollinger

Also active at: DOLFINANCE, PHARMA FLEX

since 2024

NEXTGEN INVEST SRL

Director · represented by Claire Becker

Also active at: PHARMA FLEX

since 2024

Martial DOLLINGER

Director

Also active at: DOLFINANCE, PHARMA FLEX

since 2021 · until 2024

Claire BECKER

Director

since 2021 · until 2024

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Graham Bell 8

1402 Nivelles

2.319.451.330

Dolezlaan 480

1180 Ukkel

Active since 17 March 2021

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

PHARMA TECHNOLOGY

€ 26.8 million revenue · 2025

DOLFINANCE same network

€ 116,272 gross margin · 2025

PHARMA VAT UNIT

PHARMA FLEX same network

€ 2.1 million revenue · 2025

NextGen Invest same network

€ 123,127 gross margin · 2025

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmatec.be

About

Technologies

All in One SEOBootstrapCloudflare CDNJSGoogle AnalyticsGoogle FontsLightboxMapboxNginxPHPSwiperWordPressjQueryjsDelivrreCAPTCHAunpkg

Certifications & Partners

ISO 9001FEB/VBO

Hosting & Email

Email provider

Microsoft 365

Hosting

IPV1-SIA-AS, LV

Website info

HTTPS Ja

Indexable pages 14

Languages EN

Features

Webshop Blog Newsletter Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0765.300.009
VAT number: BE 0765.300.009
Registered office: Rue Graham Bell 8, 1402 Nivelles
Names & denominations: DOLLIMMO BELGIUM
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 March 2021
Peppol: Active · Active since 21 Oct 2026
Contact: pharmatec.be

View on CBE Public ↗ Annual accounts (NBB) ↗